DIANA VUCUREVICH: Open Payments
NPI 1285758540 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$599 in 8 payments from 7 companies in 2025. Trend: 2023 $852 · 2024 $51 · 2025 $599
Food & beverage: $599
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $150 |
| E.R. Squibb & Sons, L.L.C. | 1 | $132 |
| PFIZER INC. | 1 | $118 |
| PharmaEssentia USA Corporation | 1 | $118 |
| ABBVIE INC. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $21 |
Products named: RYBREVANT, BREYANZI, IBRANCE, BESREMI, EPKINLY, DUPIXENT, NERLYNX, VENCLEXTA.
Industry payments across CO — which companies pay providers there.
